Does having low vitamin D actually increase your risk of dying from cancer?
The strongest evidence here suggests yes. A landmark genetic study using data from over 307,000 people in the UK Biobank found a clear, causal link between vitamin D deficiency and higher mortality, including from cancer [1]. The study showed that for people with a measured vitamin D level of 25 nmol/L (severely deficient), the odds of dying from any cause were 25% higher compared to those with a level of 50 nmol/L (the threshold for adequacy) [1]. This is a large, well-designed study that provides strong evidence that deficiency itself is a risk factor.
This finding is reinforced by a study of Jamaican men with prostate cancer. Men who were vitamin D deficient at the time of their diagnosis had a nearly five-fold (495%) higher risk of dying specifically from prostate cancer compared to men with sufficient levels [3]. This is a dramatic increase, though it's important to note the study was smaller (152 men) and looked at a specific cancer type [3]. Together, these two studies [1][3] converge on the same conclusion from different angles—one in a general population, one in a specific cancer group—which strengthens the overall case that deficiency is dangerous.
If deficiency is bad, why don't vitamin D pills clearly prevent cancer deaths?
This is the key puzzle. While deficiency is linked to higher mortality, giving vitamin D supplements to a general population has not consistently shown a reduction in cancer deaths. A large, 5-year Finnish trial gave 2,495 older adults either a placebo or high doses of vitamin D (up to 3200 IU/day) and found no significant reduction in cancer incidence or cancer death [2]. The likely reason? The participants were not deficient to begin with—their average vitamin D level was already adequate (75 nmol/L) [2]. You can't expect a supplement to help much if the problem it's meant to fix doesn't exist in the group being studied.
A major meta-analysis (a study that combines results from 12 trials with over 72,000 people) confirmed this: overall, vitamin D supplementation did not reduce total cancer mortality [5]. However, it did find a 37% reduction in lung cancer mortality specifically [5]. This suggests that for certain cancers, or in people who are truly deficient, supplements might still help. The bottom line is that the evidence is mixed: deficiency is a clear risk, but blanket supplementation for everyone hasn't proven to be the simple solution. The benefit likely depends on your starting vitamin D level.
Could a population-wide approach, like fortifying food, make a difference?
Given the challenges with individual supplementation, some researchers have modeled the impact of a public health strategy: adding vitamin D to common foods. One modeling study estimated that if all European countries implemented widespread vitamin D food fortification, it could prevent approximately 129,000 cancer deaths per year across the continent—that's about 9% of all cancer deaths [4]. This is a projection, not a trial result, but it's based on the same 13% reduction in cancer mortality seen in meta-analyses of supplementation trials [4][6].
The logic is that fortification would raise the vitamin D levels of the entire population, especially those who are deficient, at a very low cost and without requiring individual action [6]. This approach directly targets the deficiency that the UK Biobank study [1] identified as the root cause of increased risk. While not a direct clinical trial, this modeling provides a powerful, evidence-based argument that fixing widespread deficiency at a population level could have a massive impact on cancer death rates.
About These Sources
This answer is built on 6 peer-reviewed studies — published from 2021 to 2022, 4 in Q1 journals, collectively cited 261 times — selected as the most relevant from 10 studies that passed quality screening, drawn from 55 papers retrieved from a database of over 500 million.
Sources used in this answer
Vitamin D Deficiency Increases Mortality Risk in the UK Biobank
This large genetic study (over 307,000 people) found a causal, L-shaped relationship: the risk of death (including from cancer) increased steeply as vitamin D levels dropped below 50 nmol/L, with a 25% higher odds of death at 25 nmol/L vs. 50 nmol/L.
Vitamin D supplementation and prevention of cardiovascular disease and cancer in the Finnish Vitamin D Trial: a randomized controlled trial
In a 5-year randomized trial of 2,495 older adults with adequate baseline vitamin D (75 nmol/L), high-dose vitamin D3 supplementation (up to 3200 IU/day) did not lower the incidence of major cardiovascular events or invasive cancer.
Vitamin D Deficiency at Diagnosis Increases All-Cause and Prostate Cancer-specific Mortality in Jamaican Men
Among 152 Jamaican men with prostate cancer, those with vitamin D deficiency at diagnosis had a nearly 5-fold higher risk of dying from prostate cancer and a 2.4-fold higher risk of death from any cause compared to men with sufficient levels.
Vitamin D food fortification in European countries: the underused potential to prevent cancer deaths
A modeling study estimated that current vitamin D food fortification in Europe prevents ~27,000 cancer deaths per year, and that if all countries adopted effective fortification, an additional ~129,000 cancer deaths (9% of total) could be prevented annually.
Association between Vitamin D Supplementation and Cancer Mortality: A Systematic Review and Meta-Analysis
This meta-analysis of 12 trials (72,669 participants) found that vitamin D supplementation did not reduce overall cancer mortality, but it was associated with a 37% reduction in lung cancer mortality specifically.
Potential of Vitamin D Food Fortification in Prevention of Cancer Deaths—A Modeling Study
This modeling study for Germany concluded that vitamin D food fortification could be similarly effective as supplementation in reducing cancer mortality (by ~13%) but at a much lower cost and with greater population reach.